Swati Chaturvedi · Healthcare · 2026-09-01
Move Over Ozempic, Is Hair Loss Pharma’s Next Billion-Dollar Beauty Bet?
Hair-loss treatments are attracting major investor interest as biotech companies race to develop new therapies. Could hair loss become pharma’s next big beauty opportunity? Move Over Ozempic, Is Hair Loss Pharma’s Next Billion-Dollar Beauty Bet?
Read original on Swati Chaturvedi Get the app
Licensed summary · LicensedSummary
Related briefs
- J&K FDA Bans 10 Ghee Batches Over Quality Violations: From FSSAI Number To
- What’s in your Maggi, Kurkure packets? FDA busts Rs 75-lakh racket
- Expiry dates, labels of popular snacks altered, FDA busts racket in Navi Mumbai
- I'm on a mission to convince people to work less
- Government data shows 2,223 food samples crossed pesticide safety limits